News

AddToAny

Google+ Facebook Twitter Twitter

Avoid "Wild West testing"

The IBMS has circulated a statement to all major media outlets and MPs stating that we must avoid a “Wild West testing” scenario in the UK.

The statement from IBMS President Allan Wilson stresses that members are “increasingly expressing their frustration” that it is a global supply shortage holding NHS biomedical scientists back, not a lack of capacity.

He continues: “The profession is now rightly concerned that introducing these mass testing centres may only serve to increase competition for what are already scarce supplies and that NHS testing numbers will fall if their laboratories are competing with the testing centres for COVID-19 testing kits and reagents in a ‘Wild West testing’ scenario. The UK must avoid this for the sake of patient safety.”

The statement goes on to stress the vital importance of HCPC registration and UKAS laboratory accreditation to protect patients and the public.

Allan also thanks the biomedical scientists and lab staff “who are going above and beyond to help the nation”.

Picture Credit | Getty

Related Articles

Graves disease

This is the fifth in a series of short biographies of persons whose names are directly used for diseases, conditions or syndromes familiar to those in clinical pathology laboratories.

The British Journal of Biomedical Science: Issue 3 2021 synopsis

Deputy Editor Nigel Brown provides a brief glimpse of the articles on offer in the third issue of 2021.

My lab: The laboratory that adapted

Biomedical scientist Caroline Fillmore gives a guided tour of her laboratory at the Royal Victoria Hospital, Belfast.

“Sweat sticker” to diagnose cystic fibrosis

A novel skin-mounted sticker absorbs sweat and then changes colour to provide an accurate, easy-to-read diagnosis of cystic fibrosis within minutes.

Top